An observational study to characterize the patient population diagnosed with sarcopenia.

Trial Profile

An observational study to characterize the patient population diagnosed with sarcopenia.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 May 2017

At a glance

  • Drugs Sarconeos (Primary)
  • Indications Muscular atrophy
  • Focus Adverse reactions
  • Acronyms SARA-OBS
  • Most Recent Events

    • 11 May 2017 According to a Biophytis media release, the company has received the approval from the US regulatory authorities for the recruitment of sarcopenia patients in this trial, and the first patient from the US has been enrolled in this trial. Roger A Fielding is the head researcher of this trial.
    • 03 May 2017 According to a Biophytis media release, data from this trial were presented at the 7th International Conference on Frailty & Sarcopenia Research 2017.
    • 21 Mar 2017 According to a Biophytis media release, data will be presented at the 7 th International Conference on Frailty & Sarcopenia Research 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top